ABSTRACT Background: Dietary magnesium might be related to colorectal tumor risk through the pivotal roles of magnesium in cellular metabolism, insulin resistance, and systemic inflammation. Objective: We evaluated the hypothesis of whether higher dietary magnesium intake is associated with reduced colorectal tumor risk. Design: A case-control study on colorectal adenomas (768 cases; 709 polyp-free control subjects) and a meta-analysis of colorectal adenomas (3 case-control studies) and carcinomas (6 prospective cohort studies) were conducted. Dietary magnesium was estimated from food-frequency questionnaires in the case-control study and most studies in the meta-analyses. Data analysis comprised multiple logistic regression analysis (case-control study) and fixed-and random-effects meta-analyses. Results: The case-control study showed a nonsignificant inverse association between dietary magnesium intake and risk of colorectal adenomas (OR for every 100-mg/d increase: 0.81; 95% CI: 0.62, 1.06). However, inverse associations were observed only in subjects with BMI (in kg/m 2 ) $25, in subjects aged $55 y, and for advanced adenomas. Associations did not vary by the calcium-to-magnesium intake ratio. In the meta-analysis, every 100-mg/d increase in magnesium intake was associated with 13% lower risk of colorectal adenomas (OR: 0.87; 95% CI: 0.75, 1.00) and 12% lower risk of colorectal cancer (RR: 0.88; 95% CI: 0.81, 0.97). Conclusions: Our findings support the hypothesis that higher intakes of dietary magnesium are associated with lower risk of colorectal tumors. The consumption of magnesium-rich foods may be a new avenue to explore further in the search for cancer-prevention strategies.
INTRODUCTION
Magnesium is an essential mineral, which is most notably present in foods rich in dietary fiber, nonstarchy vegetables, fruit, nuts, and dairy products. A high consumption of these foods is thought to reduce risk of colorectal cancer (1) . Magnesium is required for many physiologic processes that affect colorectal carcinogenesis, including DNA synthesis and repair, glucose metabolism, the regulation of cell proliferation and apoptosis, and defense against oxidative stress (2, 3) . Furthermore, magnesium may affect insulin sensitivity and inflammatory responses (4) (5) (6) , which also influence colorectal carcinogenesis (7) .
Indeed, magnesium hydroxide reduced the incidence of chemically induced colorectal cancer in rats (8, 9) . Its protective effect, however, might be limited to early stages in tumor development, with some evidence pointing toward the promotion of tumor growth in later stages (3) . Observational studies also suggested possible beneficial effects. The rate of colorectal cancer for people in the highest fifth of dietary magnesium intake was 41% lower than the rate of colorectal cancer for people in the lowest fifth of intake in the Swedish Mammography Cohort (10) . Most subsequent prospective cohort studies also reported inverse associations (11) (12) (13) (14) , but they tended to be weaker, were not always significant, or were visible only in analyses stratified by site, sex, or BMI. Dietary magnesium was not associated with colorectal cancer risk in a prospective study from Germany (15) . Most (16) (17) (18) (19) (20) , but not all (21, 22) , case-control studies observed lower risks of colorectal cancer in subjects with high magnesium intakes, which was also seen in 3 case-control studies in colorectal adenomas (23) (24) (25) . In one of these studies (25) , magnesium intake was most markedly associated with reduced risk of colorectal adenomas in people whose calcium intakes, compared with magnesium intakes, were relatively small. Calcium competes with magnesium for intestinal absorption and transport.
We aimed to shed additional light on the role of magnesium intake in colorectal carcinogenesis by studying advanced, nonadvanced, multiple, and single adenomas separately in a casecontrol study in which we also evaluated whether the hypothesized inverse association between dietary magnesium and adenoma risk was stronger in people with low calcium-to-magnesium intake ratios. In addition, we conducted meta-analyses of the association of magnesium intake with risks of colorectal adenomas and carcinomas. Where possible, we stratified analyses by tumor location. In addition, we explored whether the associations depended on sex and BMI.
SUBJECTS AND METHODS

Case-control study
Study population
Trained staff from 10 outpatient clinics in the Netherlands recruited cases and control subjects among all eligible people who underwent endoscopy of the large bowel between June 1997 and October 2002. The trained staff either handed eligible people the information package at the time of endoscopy or mailed the package #3 mo thereafter. Cases had to ever have had a histologically confirmed colorectal adenoma, whereas control subjects were never diagnosed with any type of polyp.
Potential participants had to be between 18 and 75 y old, be white, be able to speak Dutch, be free of hereditary colorectal cancer syndromes and chronic inflammatory bowel diseases, and lack histories of colorectal cancer and (partial) bowel resection. The overall response rate was 54% and ranged from 35% to 91% in the various outpatient clinics. A total of 1526 people gave written informed consent, completed food-frequency and general questionnaires, and agreed to provide a blood sample. Forty-nine people were excluded because their dietary data either were incomplete or resulted in implausible energy intakes.
Medical records of the remaining 768 cases and 709 control subjects were reviewed to obtain information on the indication for endoscopy, polyp history, colonoscopy completeness, and adenoma location, size, and number. Ninety-two percent of cases and 85% of control subjects underwent full endoscopy (ie, full colonoscopy or sigmoidoscopy combined with an X-ray). The case-control study was approved by the Medical Review Boards of participating hospitals and Wageningen University. All participants provided written informed consent.
Exposure assessment
The 178-item food-frequency questionnaire referred to the year before study inclusion or symptom onset (26, 27) . Data from the Dutch Food Composition Table (28) were used for conversion to daily energy and nutrient intakes. The questionnaire was suitable for ranking individuals according to most food groups and nutrients, with their 6-and 12-mo reproducibility of the assessment being moderate to high (26, 27) .
The general questionnaire inquired about demographic, socioeconomic, and lifestyle factors and medical history. It included a question on drugs used at least monthly, which was used to identify takers of magnesium-containing drugs (ie, magnesium hydroxide, carbonate, oxide, peroxide, and sulfate).
Statistical analyses
Intakes of all nutrients except alcohol were adjusted for total energy intake by obtaining the residuals of linear regression analyses of log-transformed nutrients on log-transformed total energy intake and subsequently adding the log of the nutrient intake of interest at the mean caloric intake (29) . The resulting values were exponentiated and subdivided into quantiles according to the distribution in control subjects.
Logistic regression was used to evaluate associations of energyadjusted magnesium intake and use of magnesium-containing drugs with colorectal adenoma risk. ORs for different strata were obtained by inclusion of crossproduct terms with quantiles of magnesium intake into regression models. Corresponding likelihood ratio tests provided additional evidence for or against effect modification. All models on dietary magnesium included age and total energy intake as continuous variables and sex. The following factors were evaluated as potential confounders: BMI; smoking; alcohol consumption; physical activity; education level; family history of colorectal cancer; gastrointestinal complaints; use of nonsteroidal antiinflammatory drugs and multivitamins; consumption of fruit, vegetables, and red meat; and dietary intakes of calcium, folate, zinc, fiber, riboflavin, and vitamins B-6 and B-12. Only dietary folate and vitamin B-6 altered the OR for dietary magnesium by .10% and were included in the final regression models. To test for a linear trend, the median intake in control subjects within a given exposure category was assigned to the corresponding category and subsequently evaluated as a single ordinal term. Analyses of magnesium-containing drugs were adjusted for age, sex, and bowel complaints.
We examined whether the associations depended on the histopathology, number, or location of adenomas by using multinomial logistic regression analyses. Participants with advanced adenomas had either a (tubulo)villous adenoma according to the pathology report or an adenoma $1 cm according to the endoscopy report. Multiple-adenoma patients were defined as patients diagnosed with one or more adenomas at full colonoscopy. Cases with a single adenoma who underwent a full colonoscopy were classified as subjects with distal (between the rectum and the splenic flexure) and subjects with proximal lesions. In sensitivity analyses, we restricted the analyses to people who underwent their first endoscopy; excluded users of the drug furosemide (which may increase the renal loss of magnesium) (30) , multivitamin users, and subjects who indicated having made dietary changes because of experiencing bowel complaints; and repeated the analyses by using quintiles instead of tertiles. In additional sensitivity analyses, we explored whether the associations depended on heavy alcohol consumption ($40 g/d for men and $20 g/d for women) or having diabetes because these increase renal excretion of magnesium (30) , on high physical activity because of possible losses via sweat (31) , and on older age or the presence of bowel complaints because of possible magnesium malabsorption (30) .
Meta-analysis
Study identification and selection
We performed a systematic search for publications on magnesium intake from the diet or supplements and risk of colorectal adenomas and carcinomas in PubMed (http://www.ncbi.nlm.nih. gov/pubmed) without any language restriction from 1966 to 31 July 2011 by using the search strategy implemented for the World Cancer Research Fund/American Institute for Cancer Research report (1) . Medical subject headings and text words covered a broad range of factors on foods and foods components, physical activity, and anthropometric measures. We also handsearched reference lists from retrieved articles, reviews, and meta-analyses. The complete protocol and full search strategy used is available at http://www.dietandcancerreport.org/cu/ (32). See Supplemental Text 1 under "Supplemental data" in the online issue for a description of the search terminology. The reporting on the systematic review and meta-analysis followed the preferred reporting items for systematic reviews and meta-analyses statement (33) .
MAGNESIUM INTAKE AND COLORECTAL TUMOR RISK
The flowchart shown in Figure 1 illustrates the study-selection process. An overview of the 20 original publications from which data were extracted is available online (see Supplemental Tables  1-3 under "Supplemental data" in the online issue) and is summarized in the Results. Publications that presented RR estimates and their variances or sufficient data to obtain these effect measures were eligible for inclusion in the meta-analysis. If multiple publications presented findings on the same study population, only the most recent information was used. The meta-analysis eventually comprised 9 studies, which were inclusive of our case-control study.
Statistical analyses
We first conducted a meta-analysis of the dose-response relation of magnesium from diet or supplements with risk of colorectal adenomas and carcinomas. Category-specific risk estimates were transformed into estimates of the RR by the use of an estimation of generalized least-squares for trends with assumption of a linear relation (34) . Mean or median exposure values per category level were used directly in the trend estimation when provided; otherwise, the mean exposure level for each category was computed (35) . We also performed a meta-analysis in which we compared the highest to lowest categories of intake (36) .
Fixed-and random-effects models were fitted in both types of meta-analyses for which the most adjusted risk estimate from each study was used. Heterogeneity between studies was quantified with the I 2 statistic as a measure of the proportion of total variation in estimates because of heterogeneity. We excluded one study at a time in the sensitivity analyses and prepared funnel plots to assess for small study effects that may have been caused by publication bias. The Stata/SE statistical software package was used for all data analyses (version 9.2; Stata Corp).
RESULTS
Case-control study
The study population according to case-control status is described in Table 1 . Cases were, on average, older and more likely to be men, have a higher BMI, and have ever smoked and drank more alcohol than control subjects. Cases had higher energy intakes; had higher absolute intakes of fat, folate, and vitamin B-12; and tended to consume more red meat and vegetables than did control subjects. Fewer cases than control subjects underwent endoscopy because of lower gastrointestinal complaints and used magnesium-containing drugs.
Lifestyle and medical characteristics of control subjects according to energy-adjusted dietary magnesium intake are described in Table 2 . Control subjects in the highest one-third of energy-adjusted intake of dietary magnesium were, on average, older than control subjects with lower intakes. The top one-third Tables 1-3 under "Supplemental data" in the online issue for additional description of these studies (and our case-control study).
2 The meta-analysis also included the case-control study presented in the current article. Thus, the total number of studies included was 9, 3 studies of which were case-control studies on colorectal adenomas. WCRF/AICR, World Cancer Research Fund/American Institute for Cancer Research. intake band contained more control subjects with a family history of colorectal cancer than other intake bands. The majority of control subjects underwent (full) endoscopy for the first time. Only a few control subjects reported the use of furosemide, taking magnesium-containing drugs, or having diabetes, the latter of which was more common in the top one-third intake band. A larger proportion of control subjects in the bottom one-third intake band underwent endoscopy because of bowel complaints.
The higher the dietary magnesium intake was, the lower was the risk of colorectal adenomas ( Table 3) . This particularly applied to risk of advanced and multiple adenomas (Table 3) but did not depend on their location [OR (95% CI) for highest compared with lowest tertile: 0.47 (0.28, 0.79) for proximal and 0.65 (0.46, 0.92) for distal adenomas]. The association between dietary magnesium and adenoma risk did not depend on the calcium-to-magnesium ratio (P-interaction = 0.86) or sex (P-interaction = 0.43) but depended on BMI and age (Table 3) . Inverse associations between dietary magnesium intake and adenoma risk were detected only in overweight subjects and in subjects aged $55 y. A comparable pattern was observed in analyses according to adenoma subtype (results not shown). Sensitivity analyses supported our findings; the exclusion of subjects who underwent a repeated endoscopy (OR for highest compared with lowest tertile of dietary magnesium intake: 0.68, 95% CI: 0.47, 1.00), takers of magnesium-containing drugs (OR: 0.73; 95% CI: 0.53, 1.00), furosemide users (OR: 0.68; 95% CI: 0.49, 0.93), multivitamin users (OR: 0.70; 95% CI: 0.49, 0.98), and subjects who indicated having changed their diet (OR: 0.61; 95% CI: 0.40, 0.93) did not affect the conclusions. Besides, an inverse, albeit not significant, association was also shown when quintiles of dietary magnesium intake were studied (OR for highest compared with lowest quintile: 0.72, 95% CI: 0.47, 1.10; P-linear trend = 0.07). These associations did not depend on heavy alcohol consumption, diabetes, high physical activity, or having bowel complaints (P-interaction $ 0.33). The data supported a linear dose-response relation (see Supplemental Figure 1 under "Supplemental data" in the online issue). Cases were less likely to have used magnesium-containing drugs than were control subjects (OR: 0.52; 95% CI: 0.23, 1.20), but the point estimate was imprecise and not significant.
Meta-analysis
Magnesium and colorectal adenomas
The literature search revealed 3 case-control studies on magnesium and risk of colorectal adenomas (23-25) but no prospective studies (see Supplemental Table 1 under "Supplemental data" in the online issue). The only study that made use of population control subjects did not provide cell counts or CIs and could not be included in the meta-analysis (OR for highest compared with lowest quartile: 0.43; P-linear trend = 0.030) (24) .
The meta-analysis, which, thus, was based on 2 published studies along with our case-control study and included a total of 1703 cases and 2253 control subjects, showed that the higher the intake of magnesium, the lower the risk of colorectal adenomas (OR for every 100-mg/d increase in dietary magnesium intake: 0.87; 95% CI: 0.75, 1.00; Figure 2) . A linear doseresponse relation could be assumed (see Supplemental Figure 2 under "Supplemental data" in the online issue).
One of the included studies observed an inverse (but not significant) association with dietary magnesium, whereas a significant and stronger inverse association was seen when magnesium from supplements and magnesium from the diet were studied jointly (25) . The use of combined rather than dietary estimates for this study in the meta-analysis increased the strength of the association (OR for every 100-mg/d increase in magnesium intake: 0.80; 95% CI: 0.71, 0.90). The highest compared with lowest comparison also showed that subjects with higher magnesium intakes had lower colorectal adenoma risks (OR: 0.76; 95% CI: 0.60, 0.96; see Supplemental Figure 1 under "Supplemental data" in the online issue).
Magnesium and colorectal cancer
Eleven publications on 7 case-control studies (16) (17) (18) (19) (20) (21) (22) (37) (38) (39) (40) on magnesium intake and colorectal cancer were identified, and all of them were based on dietary estimates (see Supplemental  Table 2 under "Supplemental data" in the online issue). A metaanalysis was not conducted because only 2 of the 11 publications reported sufficient data to undertake a meta-analysis (16, 22) . Three (16) (17) (18) (19) (20) of the 7 (16) (17) (18) (19) (20) case-control studies showed inverse associations but only in the smallest of these three studies (399 cases and 399 control subjects) (16) was significance reached. The study in 1993 cases and 2410 control subjects showed no evidence for an association (39, 40) and neither did the 3 studies with ,300 cases and control subjects each (21, 22, 38) . In addition, 6 prospective cohort studies were identified (10-15), which included a total of 5834 cases. Follow-up time ranged from 7.9 to longer than 17 y, and 3 of these studies included only women (see Supplemental Table 3 under "Supplemental data" in the online issue). The highest compared with lowest category of intake (RR: 0.84; 95% CI: 0.73, 0.97; see Supplemental Figure 1 under "Supplemental data" in the online issue) as well as the dose-response meta-analysis (Figure 2) showed inverse associations of similar magnitude for colorectal, colon, and rectum cancer risks. Between-study heterogeneity was observed, but this appeared to be largely due to the Swedish Mammography Cohort (10) . Exclusion of the latter study only slightly attenuated the pooled RR [RR for colorectal cancer for every 100-mg/d increase in magnesium intake: 0.90; 95% CI: 0.83, 0.99; I 2 = 5.4%, P for heterogeneity = 0.38; compared with RR of 0.88 (Figure 2 ) when all studies were included]. Doseresponse graphs suggested a linear relation (see Supplemental Figure 2 under "Supplemental data" in the online issue).
Two studies presented analyses according to sex and obesity. The Netherlands Cohort Study on Diet and Cancer reported comparable results for men and women and observed an inverse dose-response relation for colon and proximal cancer in overweight individuals only (13) . In contrast, the Japan Public Health 1 ORs (95% CIs) were adjusted for age, sex, total energy intake, dietary folate, and vitamin B-6. 2 OR for every 100-mg/d increase in magnesium intake: 0.81 (95% CI: 0.62, 1.06).
3 P-interaction = 0.011. 4 P-interaction = 0.081. 5 Despite not being significant, the odds of having advanced rather than nonadvanced colorectal adenomas in people in the highest tertile of dietary magnesium intake seemed to be lower than the odds of having advanced rather than nonadvanced colorectal adenomas in people in the lowest tertile of dietary magnesium intake (OR: 0.66; 95% CI: 0.42, 1.02; Plinear trend = 0.064).
6 Applies to subjects who underwent a full endoscopy (700 cases and 602 control subjects). The difference between associations with multiple and single adenomas was not significant (OR for having multiple rather than single adenomas for the highest compared with the lowest tertile of dietary magnesium: 0.81; 95% CI: 0.52, 1.26; P-linear trend = 0.36).
Center-based Prospective Study only detected associations in men with BMI (in kg/m 2 ) ,25 (14) . The literature search did not identify any studies on magnesium-containing drugs.
DISCUSSION
In addition to conducting case-control analyses of colorectal adenomas, we provided a comprehensive overview of the epidemiologic evidence on magnesium and colorectal tumors available. Both our case-control study and the meta-analyses showed inverse associations between magnesium intake and risk of colorectal tumors. In the case-control study, associations with colorectal adenomas were restricted to overweight individuals and subjects aged $55 y and were more clearly visible for advanced and multiple adenomas. The associations did not depend on the calcium-to-magnesium intake ratio. Neither the case-control study nor the meta-analysis suggested differential associations according to tumor location.
The available data have limitations. Our case-control study included more cases than any other identified study on magnesium intake and colorectal adenomas, but overall, the available evidence was limited. Only 3 studies on adenomas and 6 studies on carcinomas have been published to our knowledge. In contrast to the cohort studies on which the meta-analysis of colorectal cancer was based, the meta-analysis of colorectal adenomas included only endoscopy-based case-control studies. Endoscopybased populations may include a proportion of people with chronic diarrhea or intestinal and biliary fistulae in whom magnesium absorption is impaired (30, 41) . Because the association between dietary magnesium intake and risk of colorectal adenomas was similar in subjects with and without bowel complaints, the presence of this subcategory does not compromise the validity in our FIGURE 2. Dose-response meta-analysis of magnesium intake and risk of colorectal adenomas and cancer. The center of the solid boxes represents the sizes of the RR for each study, with the area of these boxes representing the weight that each study contributes to the overall RR. Horizontal lines indicate the corresponding 95% CIs. The center of the diamonds indicates summary RRs, and the left and right extremes represent the corresponding CIs. *Case-control studies. D+L, DerSimonian and Laird (random-effects) model; I-V, prospective cohort studies I-V that represent the inverse-variance-weighted (fixed-effects) model.
case-control study. Recall bias, however, cannot be ruled out in any case-control study. Although we appropriately took into account potential confounders, the possibility of residual confounding can also never be ruled out. The same applies to the other studies included in the meta-analysis.
Selection bias is always a potential issue in case-control studies. The overall response rate of our case-control study was 55% and varied between hospitals that had somewhat different recruitment strategies. The available data did not allow us to explore nonresponse bias in detail. However, we reduced the possibility of selection bias by recruiting cases and control subjects among people who underwent endoscopy of the large bowel by using similar recruitment strategies. We chose this group because adenomas are common in the general population and are often only detected by chance because they are mostly asymptomatic (42) . Restriction of the analyses to participants who underwent their first endoscopy, underwent a full endoscopy, or did not report to have made dietary changes because of bowel complaints did not affect our conclusions. Although our choice of study population may have affected external validity, our selection of control subjects from endoscopy patients can, thus, be regarded as an advantage. One of the other casecontrol studies included in the meta-analysis selected cases likewise (25) .
The majority of studies included in the meta-analysis, which were inclusive of our case-control, assessed magnesium intake through food-frequency questionnaires. Food-frequency questionnaires are suitable for ranking individuals according to magnesium intake, and the reproducibility of its assessment is high (43, 44) . Thus, associations of high compared with low magnesium intakes can be investigated despite the likely underestimation of intake compared with that in food records (41) . In contrast to the US studies (11, 12), we did not take magnesium intake from supplements into account, but this has unlikely affected our findings. Supplement use is rare in the Netherlands (13, 45) , and the exclusion of multivitamin users did not change the conclusions. However, nondifferential misclassification of magnesium intake might have occurred. Magnesium from drinking water has been associated with colorectal cancer risk (46) . However, sourcespecific data on the magnesium content of drinking waters were not available in the case-control study or meta-analysis, and the loss of magnesium during food processing (31) could not be estimated. Because reporting errors also inevitably lead to some degree of measurement error, true associations between magnesium intake and risk of colorectal tumors may be stronger than observed.
In the case-control study, we observed that inverse associations between dietary magnesium and colorectal adenomas were limited to people who were overweight, which was also observed in the Netherlands Cohort Study on Diet and Cancer for colon cancer (13) and in the Health Professionals Follow-Up Study for pancreatic cancer (47) . This effect modification might have been a result of effects of magnesium on insulin resistance and responses, which are thought to play a role in carcinogenesis (7) . Magnesium supplementation reduced insulin resistance and improved insulin sensitivity and b cell function even in patients without diabetes (4) (5) (6) . The postulated role of magnesium in the causation of type 2 diabetes (48) and increased risk of colorectal cancer seen in type 2 diabetes patients (49) lend additional support for this mechanism. However, the Japan Public Health Center-based Prospective study only observed an inverse association in subjects with BMI ,25 (14) . b Cell function is relatively low in lean Asian people (50) , and dietary magnesium could, thus, be mostly beneficial in this subgroup.
Our case-control study and meta-analysis suggested a linear dose-response relation, which was contradicted by only one study in which an inverse association was seen when magnesium intakes from the diet and supplements were studied jointly but not when dietary intakes were considered alone (25) . These observations may suggest that the achievement of magnesium homeostasis (30) does not suffice to explain the association between magnesium intake and colorectal tumor risk. However, different individuals may require different dietary intake levels to achieve homeostasis depending on their age, sex, and calcium intake. We did not find differences according to sex in our studies and we observed an inverse association only in participants $55 y old. This observation requires confirmation because it is hard to explain and may have been by chance: In contrast to the Tennessee Colorectal Polyp Study (25), we did not find evidence for effect modification by the calcium-to-magnesium intake ratio in the case-control study. Differences in genetic makeup between our study populations might potentially account for this discrepancy. For instance, the Tennessee Colorectal Polyp Study showed that carriers of the Thr1482Ile allele of the transient receptor potential melastatin 7 gene, which plays a role in magnesium homeostasis, were at greater risk of adenomas, particularly if carriers had relatively high calcium compared with magnesium intakes (25) .
We investigated associations for advanced, nonadvanced, multiple, and single adenomas and carcinomas separately because animal studies suggested that magnesium may be beneficial only in the early stages of colorectal carcinogenesis (3). In line with this hypothesis, the meta-analysis showed strikingly similar risk estimates for adenoma and carcinomas. The case-control study, however, pointed toward stronger associations with advanced and multiple than with nonadvanced or single adenomas. This finding warrants replication because it may imply that magnesium might also affect intermediate stages of colorectal carcinogenesis.
Whether magnesium-containing drugs, such as some laxatives and antacids, affect colorectal cancer tumor risk remains to be established. In line with a study in rats (8, 9), we observed a nonsignificant reduced risk of colorectal adenomas in takers of magnesium-containing drugs, which are prescribed for hyperacidity, constipation, or severe magnesium deficiency (30) . Nonetheless, the statistical power was limited, and only some of the control subjects who were prescribed magnesium-containing drugs were free of bowel complaints, which made it hard to separate effects of treatment and indication. Furthermore, the use of laxatives was not associated with colorectal tumor risk in US women (51, 52) .
In conclusion, we observed that magnesium intake was inversely associated with risk of colorectal adenomas and colorectal cancer. However, the number of studies on this topic is small. In particular, the observation that the association was limited to overweight individuals in the case-control study requires confirmation. Elucidation of pathways that involve dietary magnesium and insulin resistance in colorectal carcinogenesis is also warranted.
